Disingenous is a bit harsh.
Burn wounds was a staffing issue i spoke about ages ago.
Sepsis was a plasma conc issue.
They are looking for an application with a target market.
If they don't get sepsis they don't get sepsis.
But this data clearly shows a remarkable effect on urinary tract bacteria levels.
Better than wasting time on alternate applications. Find a path to profitability.
Would have been long ago if plasma concentrations were the same in humans as rats.
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $45.92K | 107.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |